Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

December 1, 2022 - 15:00 GMT

This webinar will discuss the integrated use of pan-cancer gene expression analysis with Akoya Bioscience’s multiplexed immunofluorescence workflow on NMIBC FFPE tissues to find a predictive biomarker panel capable of stratifying patients who will benefit from BCG immunotherapy and to identify new targets for further investigation of therapeutic strategies for BCG-unresponsive tumours.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe